Overview
Methodology This is a single-center study carried out as part of routine patient care.
The aim of the study is to determine the performance of the 2nd generation TB-IGRA test in the diagnosis of tuberculosis.
Description
It is planned to include 500 patients. An enrolment of 455 subjects will enable us to demonstrate sensitivity-specificity levels of 92% for a 95% confidence interval and a 0.05 degree of precision. To take account of non-analyzable samples or tests, the investigator will include 500 subjects
Eligibility
Inclusion Criteria:
- Individual at least 18 years of age
- Patient presenting for treatment of tuberculosis disease
- Having undergone or benefiting from screening for tuberculosis using a medically prescribed reference IGRA test.
- Informed patient who has not expressed opposition to participating in the study.
French-speaking patient with unambiguous understanding of oral and written instructions.
Exclusion Criteria:
Persons in a period of exclusion from another study
- Pregnant, parturient or breast-feeding women;
- Person deprived of liberty by judicial or administrative decision